AXSOME THERAPEUTICS, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-4
Book Value Per Share
$2
Free Cash Flow Per Share
$-2
Cash Per Share
$6
Revenue Per Share
$13
OCF Per Share
$-2
Return on Equity
-252.1%
Return on Assets
-29.1%
Return on Invested Capital
-59.4%
Debt to Equity
1.33
Current Ratio
1.55
Quick Ratio
1.48
Asset Turnover
1.01
Days Sales Outstanding
128.32
Days Payables Outstanding
503.83
Days Inventory On Hand
214.78
Cash Conversion Cycle
-160.74
R&D / Revenue
28.7%
SBC / Revenue
14.7%
Capex / Revenue
0.1%
Working Capital
$210M
Net Current Asset Value
$-13M
Invested Capital
$206M
OCF / Net Income
0.51
FCF / Net Income
0.51
Accruals Ratio (Sloan)
-13.0%
Net Debt
$-205M
Net Debt / EBITDA
1.23
Interest Coverage
10.47
Cash Coverage
5.86
Capex Coverage
-194.59
Tangible Common Equity
$36M
TCE / Total Assets
5.2%
Goodwill / Total Assets
1.7%
NOPAT
$-132M
Cash ROIC
-42.3%
WC / Revenue
32.9%
Capex / D&A
0.95
Reinvestment Rate
0.0%
Asset Growth vs Revenue Growth
-44.2%
Book Value 5Y CAGR
-4.9%
Stock Price (FY-end)
$183
Market Cap
$9.09B
P/S Ratio
14.23
P/B Ratio
102.90
P/TB Ratio
254.26
Enterprise Value
$8.88B
EV / Sales
13.91
FCF Yield
-1.0%
Shareholder Yield
-1.0%
R&D Yield
2.0%
Capex Yield
0.0%
Shares Variation (YoY)
3.8%
Beta (5Y)
0.94
Cost of Equity
9.2%
Cost of Debt (after tax)
-10.7%
52W High
$183
52W Low
$80
Trailing Return 1Y
110.7%
Trailing Return 5Y
116.2%
F-Score (Piotroski)
5.00
M-Score (Beneish)
-2.48
Z-Score (Altman)
6.91
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.